Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain activation patterns and cognitive processing speed in patients with pediatric-onset multiple sclerosis.
Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses.
Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one - Time administration of encephalitogenic T cells.
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.
Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
The contribution of optical coherence tomography in neurodegenerative diseases.
Caregiving in multiple sclerosis.
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
Regulatory T Cells in Central Nervous System Injury: A Double-Edged Sword.
A Low-Cost Cognitive Rehabilitation With a Commercial Video Game Improves Sustained Attention and Executive Functions in Multiple Sclerosis: A Pilot Study.
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.
Site-Specific Chemokine Expression Regulates Central Nervous System Inflammation and Determines Clinical Phenotype in Autoimmune Encephalomyelitis.
Lesional accumulation of CD8(+) cells in sciatic nerves of experimental autoimmune neuritis rats.
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.
Acquired Immunologic Neuropathies.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling.
Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: Role of cyclooxygenase-2.
Pages
« first
‹ previous
…
651
652
653
654
655
656
657
658
659
…
next ›
last »